Digital transformation is changing the landscape of the clinical trials consenting process.
In this webinar, 5thPort examines e-consenting regulations and operational considerations, including:
– The ethical and regulatory framework concerning e-consent, particularly in relation to the new FDA guidelines.

– Strategies to enhance patient comprehension while gaining practical insights into implementing e-consent technology.

– The most common reasons organisations are hesitant to make the jump from paper to an e-consent solution.

– What works (and what to look out for) when e-consenting in decentralised and hybrid clinical trials.